We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-4 of 4

FDA Regulatory and Compliance Monthly Recap July 2018
  • Loeb & Loeb LLP
  • USA
  • July 9 2018

The Office of Prescription Drug Promotion (OPDP) issued separate untitled letters to Pfizer and Arog raising concerns about promotional materials. The


FDA Finalizes Guidance on Medical Product Communications that are Consistent with Approved Labeling
  • Loeb & Loeb LLP
  • USA
  • June 26 2018

Earlier this month, FDA issued a final guidance titled “Medical Product Communications that are Consistent with the FDA-Required Labeling - Questions


FDA Regulatory and Compliance Monthly Recap May 2018
  • Loeb & Loeb LLP
  • USA
  • May 6 2018

In the FDA’s Drug Safety Priorities Report 2017, CDER Director Janet Woodcock said drug safety requires an interdisciplinary approach with proactive